Zimmer Biomet Holdings (ZBH) Tops Q4 EPS by 5c; offers guidance

Zimmer Biomet Holdings (NYSE: ZBH) reported Q4 EPS of $2.20, $0.05 better than the analyst estimate of $2.15. Revenue for the quarter came in at $1.94 billion versus the consensus estimate of $1.93 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY2024 EPS of $8.00-$8.15, versus the consensus of $7.95.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Piper Sandler on Fervo Energy (FRVO): 'Capital Access Supports Potential Upside'